Clinical trial on menorrhagia

Clinical evaluation of Odhiyampattai kudineer a siddha drug for Vali Perumpadu -as a Pilot study - Vali perumpadu.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011798

Enrollment

Registered

2018-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- excessive or prolonged menstrual bleeding

Interventions

Intervention1: odhiyampattai kudineer: oral administration 50 ml b.d. for 7 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Age: 16-40 years Patient having the symptoms of increased reddish black menstrual bleeding. Blood clots seen in the menstrual bleeding Patient willing to undergo routine blood investigation. Patient willing to participate in trial and signing in consentform. Patient willing to undergo Usg_pelvis( to rule out any pelvic pathology etc)

Exclusion criteria

Exclusion criteria: 1.Fibroid uterus 2.Endometriosis 3.Adenomyosis 4.Uterine cancer 5.Endometritis 6.Cardiac disease Renal disease Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
The reduction of menstrual bleeding with Pbac score.Timepoint: after 7 days	—

Secondary

Measure	Time frame
efficacy of the drug,in regulating the menstrual flow in the future period,adverse effect of the drug if anyTimepoint: after 30 days	—

Countries

India

Contacts

Public ContactAMAmalahazel

National institute of siddha

dramalaaruldhas@gmail.com9940429202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026